Based on our experience and recent study showing preventive effect of pegylated G-CSF against neutropenia during FOLFIRINOX,[16] we would suggest that pegylated G-CSF can be an option for keeping FOLFIRINOX dose intensity, although it requires further investigation. The gene discussed is CSF3; the disease is neutropenia.